Washington Trust Bank’s ResMed RMD Stock Holding History

Washington Trust Bank’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-12	Closed	-$1K	–	908
2016 Q4	$1K	Hold	12	–	–	﹤0.01%	875
2016 Q3	$1K	Buy	+12	New	+$799	﹤0.01%	944

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Washington Trust Bank's RMD Position: Q1 2017 in Review

Washington Trust Bank sold out of ResMed (RMD) in Q1 2017, closing a stake of 12 shares — an estimated $1K sold.

Washington Trust Bank first reported a position in RMD in Q3 2016 and held it in 2 quarters. The position peaked at $1K in Q4 2016. 374 funds tracked by Wall St. Rank hold RMD as of Q1 2017.

Washington Trust Bank reported no remaining ResMed position as of Q1 2017 after selling out during the quarter.
Washington Trust Bank sold 12 ResMed shares in Q1 2017, an estimated $1K.
Washington Trust Bank first reported a position in ResMed in Q3 2016 and held it in 2 quarters.
Washington Trust Bank's ResMed position peaked at $1K in Q4 2016.
374 funds tracked by Wall St. Rank held ResMed as of Q1 2017.

Based on Washington Trust Bank's 13F filing for Q1 2017, filed 18 Apr 2017.